NYSE:MMS - MAXIMUS Stock Price, Forecast & News

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

MAXIMUS announced a quarterly dividend on Wednesday, January 8th. Stockholders of record on Friday, February 14th will be given a dividend of $0.28 per share on Friday, February 28th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.68%. The ex-dividend date of this dividend is Thursday, February 13th. View MAXIMUS's Dividend History.

MAXIMUS announced that its Board of Directors has initiated a share buyback plan on Monday, June 25th 2018, which allows the company to repurchase $200,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy up to 4.9% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's board of directors believes its shares are undervalued.

MAXIMUS, Inc. (NYSE:MMS) posted its earnings results on Thursday, February, 6th. The health services provider reported $0.91 EPS for the quarter, meeting the consensus estimate of $0.91. The health services provider had revenue of $818.23 million for the quarter, compared to analyst estimates of $797.11 million. MAXIMUS had a net margin of 8.01% and a return on equity of 20.54%. The business's revenue was up 23.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.86 EPS. View MAXIMUS's Earnings History.

MAXIMUS is scheduled to release their next quarterly earnings announcement on Thursday, May 14th 2020. View Earnings Estimates for MAXIMUS.

MAXIMUS issued an update on its FY20 earnings guidance on Thursday, February, 6th. The company provided earnings per share (EPS) guidance of $3.95 to $4.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.02. The company issued revenue guidance of $3.15 billion to $3.30 billion, compared to the consensus revenue estimate of $3.22 billion.

2 equities research analysts have issued 1 year price objectives for MAXIMUS's stock. Their forecasts range from $77.00 to $81.00. On average, they expect MAXIMUS's share price to reach $79.00 in the next year. This suggests a possible upside of 18.3% from the stock's current price. View Analyst Price Targets for MAXIMUS.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for MAXIMUS.

News stories about MMS stock have been trending very negative recently, InfoTrie Sentiment reports. The research firm rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. MAXIMUS earned a daily sentiment score of -3.0 on InfoTrie's scale. They also gave media coverage about the health services provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for MAXIMUS.

MAXIMUS saw a increase in short interest in January. As of January 31st, there was short interest totalling 1,760,000 shares, an increase of 5.4% from the January 15th total of 1,670,000 shares. Based on an average daily volume of 379,700 shares, the short-interest ratio is presently 4.6 days. Approximately 2.8% of the company's stock are short sold. View MAXIMUS's Current Options Chain.

Some companies that are related to MAXIMUS include Visa (V), Mastercard (MA), Fidelity National Information Servcs (FIS), Fiserv (FISV), Automatic Data Processing (ADP), Global Payments (GPN), Worldpay (WP), Paychex (PAYX), FleetCor Technologies (FLT), Total System Services (TSS), Broadridge Financial Solutions (BR), Jack Henry & Associates (JKHY), The Western Union (WU), WEX (WEX) and Genpact (G).

Based on aggregate information from My MarketBeat watchlists, some companies that other MAXIMUS investors own include Altria Group (MO), Tesla (TSLA), Bank of America (BAC), Southwest Airlines (LUV), Wells Fargo & Co (WFC), Gilead Sciences (GILD), Intel (INTC), Qorvo (QRVO), AbbVie (ABBV) and Bristol-Myers Squibb (BMY).

MAXIMUS's stock is owned by a number of of institutional and retail investors. Top institutional investors include Victory Capital Management Inc. (6.72%), Victory Capital Management Inc. (6.69%), State Street Corp (3.26%), FMR LLC (2.50%), Bank of New York Mellon Corp (1.66%) and Charles Schwab Investment Management Inc. (1.57%). Company insiders that own MAXIMUS stock include David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Russell A Beliveau and Thomas D Romeo. View Institutional Ownership Trends for MAXIMUS.

MMS stock was sold by a variety of institutional investors in the last quarter, including Skandinaviska Enskilda Banken AB publ , Bamco Inc. NY, P2 Capital Partners LLC, FIL Ltd, AJO LP, DekaBank Deutsche Girozentrale, AXA and Standard Life Aberdeen plc. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Raymond B Ruddy, Richard A Montoni, Russell A Beliveau and Thomas D Romeo. View Insider Buying and Selling for MAXIMUS.

MMS stock was purchased by a variety of institutional investors in the last quarter, including Pictet Asset Management Ltd., State of Michigan Retirement System, FMR LLC, Charles Schwab Investment Management Inc., UBS Group AG, Renaissance Technologies LLC, Alliancebernstein L.P. and Handelsbanken Fonder AB. View Insider Buying and Selling for MAXIMUS.

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of MMS stock can currently be purchased for approximately $66.78.

MAXIMUS has a market capitalization of $4.27 billion and generates $2.89 billion in revenue each year. The health services provider earns $240.82 million in net income (profit) each year or $3.72 on an earnings per share basis. MAXIMUS employs 29,600 workers across the globe.View Additional Information About MAXIMUS.

The official website for MAXIMUS is http://www.maximus.com/.

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]